Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1987 1
1990 1
1991 7
1992 3
1993 6
1994 3
1995 8
1996 5
1997 7
1998 7
1999 7
2000 10
2001 14
2002 18
2003 13
2004 16
2005 21
2006 29
2007 18
2008 24
2009 20
2010 30
2011 45
2012 64
2013 54
2014 71
2015 60
2016 64
2017 41
2018 41
2019 32
2020 38
2021 70
2022 63
2023 64
2024 50
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

907 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.
André F, Hee Park Y, Kim SB, Takano T, Im SA, Borges G, Lima JP, Aksoy S, Gavila Gregori J, De Laurentiis M, Bianchini G, Roylance R, Miyoshi Y, Armstrong A, Sinha R, Ruiz Borrego M, Lim E, Ettl J, Yerushalmi R, Zagouri F, Duhoux FP, Fehm T, Gambhire D, Cathcart J, Wu C, Chu C, Egorov A, Krop I. André F, et al. Among authors: aksoy s. Lancet. 2023 May 27;401(10390):1773-1785. doi: 10.1016/S0140-6736(23)00725-0. Epub 2023 Apr 20. Lancet. 2023. PMID: 37086745 Clinical Trial.
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.
Saatci O, Kaymak A, Raza U, Ersan PG, Akbulut O, Banister CE, Sikirzhytski V, Tokat UM, Aykut G, Ansari SA, Dogan HT, Dogan M, Jandaghi P, Isik A, Gundogdu F, Kosemehmetoglu K, Dizdar O, Aksoy S, Akyol A, Uner A, Buckhaults PJ, Riazalhosseini Y, Sahin O. Saatci O, et al. Among authors: aksoy s. Nat Commun. 2020 May 15;11(1):2416. doi: 10.1038/s41467-020-16199-4. Nat Commun. 2020. PMID: 32415208 Free PMC article.
Microbiota in disease-transmitting vectors.
Wang J, Gao L, Aksoy S. Wang J, et al. Among authors: aksoy s. Nat Rev Microbiol. 2023 Sep;21(9):604-618. doi: 10.1038/s41579-023-00901-6. Epub 2023 May 22. Nat Rev Microbiol. 2023. PMID: 37217793 Review.
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, Alves G, Lima IPF, Hughes BGM, Pointreau Y, Aksoy S, Laban S, Greil R, Burian M, Hetnał M, Delord JP, Mesía R, Taberna M, Waldron JN, Simon C, Grégoire V, Harrington KJ, Swaby RF, Zhang Y, Gumuscu B, Bidadi B, Siu LL; KEYNOTE-412 Investigators. Machiels JP, et al. Among authors: aksoy s. Lancet Oncol. 2024 May;25(5):572-587. doi: 10.1016/S1470-2045(24)00100-1. Epub 2024 Mar 29. Lancet Oncol. 2024. PMID: 38561010 Clinical Trial.
World neglected tropical diseases day.
Hotez PJ, Aksoy S, Brindley PJ, Kamhawi S. Hotez PJ, et al. Among authors: aksoy s. PLoS Negl Trop Dis. 2020 Jan 29;14(1):e0007999. doi: 10.1371/journal.pntd.0007999. eCollection 2020 Jan. PLoS Negl Trop Dis. 2020. PMID: 31995572 Free PMC article.
Cancer Prevalence Across Vertebrates.
Compton ZT, Harris V, Mellon W, Rupp S, Mallo D, Kapsetaki SE, Wilmot M, Kennington R, Noble K, Baciu C, Ramirez L, Peraza A, Martins B, Sudhakar S, Aksoy S, Furukawa G, Vincze O, Giraudeau M, Duke EG, Spiro S, Flach E, Davidson H, Zehnder A, Graham TA, Troan B, Harrison TM, Tollis M, Schiffman JD, Aktipis A, Abegglen LM, Maley CC, Boddy AM. Compton ZT, et al. Among authors: aksoy s. Res Sq [Preprint]. 2023 Jul 6:rs.3.rs-3117313. doi: 10.21203/rs.3.rs-3117313/v1. Res Sq. 2023. Update in: Cancer Discov. 2024 Oct 24:OF1-OF18. doi: 10.1158/2159-8290.CD-24-0573 PMID: 37461608 Free PMC article. Updated. Preprint.
Sonoelastography findings of myofibroblastoma.
Ozgul HA, Akin IB, Altay C, Durak MG, Aksoy SO, Balci P. Ozgul HA, et al. Among authors: aksoy so. North Clin Istanb. 2022 Aug 17;9(4):408-410. doi: 10.14744/nci.2021.73693. eCollection 2022. North Clin Istanb. 2022. PMID: 36276559 Free PMC article.
907 results